Different molecular mechanisms involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient fibroblasts by Van Beersel, G. et al.
RESEARCH OUTPUTS / RÉSULTATS DE RECHERCHE
Author(s) - Auteur(s) :
Publication date - Date de publication :
Permanent link - Permalien :
Rights / License - Licence de droit d’auteur :
Bibliothèque Universitaire Moretus Plantin
Institutional Repository - Research Portal
Dépôt Institutionnel - Portail de la Recherche
researchportal.unamur.be
Different molecular mechanisms involved in spontaneous and oxidative stress-
induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient
fibroblasts
Van Beersel, G.; Tihon, E.; Demine, S.; Hamer, I.; Jadot, M.; Arnould, T.
Published in:
Bioscience reports
DOI:
10.1042/BSR20120104
Publication date:
2013
Document Version
Publisher's PDF, also known as Version of record
Link to publication
Citation for pulished version (HARVARD):
Van Beersel, G, Tihon, E, Demine, S, Hamer, I, Jadot, M & Arnould, T 2013, 'Different molecular mechanisms
involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1
(TPP-1)-deficient fibroblasts', Bioscience reports, vol. 33, no. 2, pp. 243-258.
https://doi.org/10.1042/BSR20120104
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 23. Jun. 2020
Biosci. Rep. (2013) / 33 / art:e00023 / doi 10.1042/BSR20120104
Different molecular mechanisms involved in
spontaneous and oxidative stress-induced
mitochondrial fragmentation in tripeptidyl
peptidase-1 (TPP-1)-deficient fibroblasts
Guillaume VAN BEERSEL*, Eliane TIHON*, Ste´phane DEMINE*, Isabelle HAMER†, Michel JADOT† and
Thierry ARNOULD*1
*Laboratory of Biochemistry and Cellular Biology (URBC), NAmur Research Institute for LIfe Sciences (NARILIS), University of Namur
(FUNDP), rue de Bruxelles, 61, 5000 Namur, Belgium, and †Unity of Research in Molecular Physiology (URPhyM), Laboratory of
Physiological Chemistry, Namur Research Institute for LIfe Sciences (NARILIS), University of Namur (FUNDP), rue de Bruxelles,
61, 5000 Namur, Belgium
Synopsis
NCLs (neuronal ceroid lipofuscinoses) form a group of eight inherited autosomal recessive diseases characterized by
the intralysosomal accumulation of autofluorescent pigments, called ceroids. Recent data suggest that the pathogen-
esis of NCL is associated with the appearance of fragmented mitochondria with altered functions. However, even if an
impairement in the autophagic pathway has often been evoked, the molecular mechanisms leading to mitochondrial
fragmentation in response to a lysosomal dysfunction are still poorly understood. In this study, we show that fibro-
blasts that are deficient for the TPP-1 (tripeptidyl peptidase-1), a lysosomal hydrolase encoded by the gene mutated
in the LINCL (late infantile NCL, CLN2 form) also exhibit a fragmented mitochondrial network. This morphological
alteration is accompanied by an increase in the expression of the protein BNIP3 (Bcl2/adenovirus E1B 19 kDa inter-
acting protein 3) as well as a decrease in the abundance of mitofusins 1 and 2, two proteins involved in mitochondrial
fusion. Using RNAi (RNA interference) and quantitative analysis of the mitochondrial morphology, we show that the
inhibition of BNIP3 expression does not result in an increase in the reticulation of the mitochondrial population in
LINCL cells. However, this protein seems to play a key role in cell response to mitochondrial oxidative stress as it
sensitizes mitochondria to antimycin A-induced fragmentation. To our knowledge, our results bring the first evidence
of a mechanism that links TPP-1 deficiency and oxidative stress-induced changes in mitochondrial morphology.
Key words: Bcl2/adenovirus E1B 19 kDa protein interacting protein 3 (BNIP3), confocal microscopy, late infantile
neuronal ceroid lipofuscinosis (LINCL), mitochondrion, mitofusins
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INTRODUCTION
LSDs (lysosomal storage diseases) represent diverse sets of con-
ditions resulting from an impaired uptake, sorting or digestion of
the material captured by cells during endocytosis or autophagy
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Abbreviations used: AR, aspect ratio; BNIP3, Bcl2/adenovirus E1B 19 kDa interacting protein 3; [Ca2+ ]mt, mitochondrial matrix Ca2+ ; CTL, control; Drp1, dynamin related protein
1; ER, endoplasmic reticulum; FCCP, carbonyl cyanide p-trifluoromethoxyphenylhydrazone; FF, form factor; Fis1, fission 1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HADHA,
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase; HSP, heat-shock protein; IMM, inner mitochondrial membrane; KRH buffer, Krebs-Ringer Hepes buffer;
LSD, lysosomal storage disease; MAM, mitochondrial associated membranes; MCFR, mean channel fluorescence ratio; MEM, minimum essential medium; MFF, mitochondrial fission
factor; Mfn1, mitofusin 1; Mfn2, mitofusin 2; MLIV, mucolipidosis type IV; NCL, neuronal ceroid lipofuscinosis; LINCL, late infantile NCL; OMM, outer mitochondrial membrane; Opa1,
optic atrophy factor 1; ROS, reactive oxygen species; RNAi, RNA interference; RT–qPCR, reverse transcription-quantitative PCR; siRNA, small interfering RNA; SOD, superoxide
dismutase; TMRE, tetramethylrhodamine ethyl ester; TPP-1, tripeptidyl peptidase-1.
1 To whom correspondence should be addressed (email thierry.arnould@fundp.ac.be).
[1]. So far, about 50 LSDs have been described. These autosomal
recessive diseases can be caused by defects in soluble enzymes,
in non-enzymatic lysosomal proteins or even in non-lysosomal
proteins that alter lysosomal function [1]. Among these diseases,
NCLs (neuronal ceroid lipofuscinoses) form a group of inher-
ited autosomal recessive disorders known as the most common
c© 2013 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/
by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
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neurodegenerative diseases in children and are characterized
by the intralysosomal accumulation of autofluorescent pigments
called ceroids [2]. NCLs result from mutations in one of the eight
CLN genes and are classified according to the onset of the dis-
ease [2]. The CLN2 gene, mutated in the LINCL (late infan-
tile NCL), encodes TPP-1 (tripeptidyl peptidase-1), a lyso-
somal hydrolase, which is involved in the degradation of sev-
eral proteins such as the c-subunit of ATPsynthase, neuromedin
B, cholecystokinin and the pro-apoptotic protein Bid [3–7].
Like the other NCLs, LINCL is characterized by seizures, pro-
gressive mental decline, loss of vision, impairment of locomotor
function and shortened lifespan [8,9]. Most of these symptoms re-
flect severe neurodegeneration (mostly in the hypothalamus and
the cerebellum) as well as astrocyte activation and gliosis [8].
Although these monogenic diseases are rather simple in terms
of causative defects, biochemical and cellular cascades of events
subsequent to the original lysosomal disorder are very complex.
Several common and uncommon pathogenic cascades have been
described in the LSDs, such as accumulation of secondary meta-
bolites, alteration of calcium homoeostasis, generation of oxid-
ative stress, inflammation and modifications in lipid trafficking,
autophagy and ER (endoplasmic reticulum) stress (reviewed in
[10]). Several studies indicate that mitochondria are often dam-
aged in case of LSD [11–13]. However, to our knowledge, nothing
is known about the putative impact of lysosomal storage on the
morphology and the functions of mitochondria in LINCL.
Mitochondria support many cellular functions, such as ATP
production, regulation of calcium homoeostasis, NEFA (non-
esterified fatty acid) β-oxidation, haem and cluster [Fe–S] syn-
theses [14]. They are very dynamic organelles that can adopt
various morphologies in terms of sizes and shapes [15]. The
dynamic morphology of the mitochondria ranges from an elong-
ated network to a fragmented aspect, depending on cell condi-
tions such as stress, cell cycle phase, energy needs and bioener-
getic status of the organelle and is regulated by frequent cycles
of mitochondrial fusion and fission [16]. So far, in eukaryotes,
several proteins have been identified as regulating those events.
Among them, Mfn1 (mitofusin 1) and Mfn2 (mitofusin 2) are
two GTPases involved in the fusion of the OMM (outer mito-
chondrial membrane) [16]. The fusion of the IMM (inner mi-
tochondrial membrane) is ensured by the Opa1 (optic atrophy
factor 1) GTPase. Fission is mediated by the action of proteins
called MFF (mitochondrial fission factor), Fis1 (fission 1) and
Drp1 (dynamin-related protein 1) [16]. MFF and Fis 1 are loc-
alized in the OMM and recruit Drp1, a cytosolic GTPase that,
once recruited, oligomerizes around the mitochondria and forms
a constriction ring [16]. So far, mitochondrial fragmentation has
been reported in several LSDs such as mucolipidosis (I, II, IV
types), GM1-gangliosidosis, nephropathic cystinosis and NCL
(CLN1 and CLN6 forms) [12,13,17–19]. Even if, in vitro, this
fragmented morphology is not associated with a modification of
mitochondrial calcium concentration or spontaneous cell death,
it has been suggested that it could impair the ‘calcium buffering
capacity’ of this organelle in response to a particular stimulus
[18]. Indeed, Kiselyov and co-workers have shown that after
cell stimulation with bradykinin, a Ca2 + -mobilizing agonist, the
mitochondrial calcium loading was reduced in MLIV (mucol-
ipidosis type IV) fibroblasts when compared with control fibro-
blasts [19]. In contrast, a mitochondrial matrix calcium overload
was observed after histamine stimulation in a model of GM1
gangliosidosis [20]. These observations reveal that the impact of
a lysosomal dysfunction on the mitochondrial calcium homoeo-
stasis could be more complex than initially proposed [20].
Furthermore, several studies suggest that the accumulation of
non-degraded material in lysosomes could also modify both the
expression of genes encoding mitochondrial proteins and the mi-
tochondrial lipid content. For example, it has been shown that the
expression of several subunits of the complex V (Fo/F1-ATP syn-
thase) is increased in the cultured renal proximal tubule epithelial
cells isolated from patients suffering from nephropathic cystin-
osis [21]. Likewise, mutations in the gene encoding the CLN6
protein would lead to an increased expression of MnSOD (man-
ganese superoxide dismutase) (SOD2) an antioxidant enzyme
located within the mitochondrial matrix [22].
Our results suggest that a TPP-1 deficiency in fibroblasts in-
duces a fragmentation of the mitochondrial network, probably
due to a reduction in the abundance of both Mfn1 and Mfn2. This
accentuated fragmentation of mitochondria is not accompanied
by changes either in the matrix calcium concentration or in the
abundance of ROS (reactive oxygen species) whatever it is in
basal or in stress-induced conditions. In contrast, an increase
in the expression of BNIP3 (Bcl2/adenovirus E1B 19 kDa inter-
acting protein 3), a pro-apoptotic BH3-only protein, described to
induce mitochondrial dysfunction in several cell types [23,24],
was observed in TPP-1-deficient cells. Applying an RNAi (RNA
interference) approach, it appears that BNIP3 was not involved in
the fragmentation of the mitochondrial network in LINCL cells
in basal conditions. However, interestingly this protein seems to
sensitize mitochondria of TPP-1-deficient cells to further mito-
chondrial fragmentation induced by antimycin A. Altogether, our
results suggest that cells that display a deficiency in TPP-1 might
be more sensitive to an additional stress targeting mitochondria,
such as an oxidative stress induced by a respiratory chain defect.
MATERIALS AND METHODS
Cell cultures
The skin fibroblast cell lines either deficient for the TPP-1 activ-
ity (LINCL, GM09404) or control fibroblasts (CTL, GM02456)
were purchased from the Coriell Institute for Medical Research.
Skin fibroblasts were grown in Eagle’s MEM (minimum essen-
tial medium) supplemented with 2 mM glutamine, 100 mM non-
essential amino acids, 100 mM pyruvate and 10 % (v/v) FBS
(fetal bovine serum) (complete MEM). At confluence, skin fibro-
blasts were trypsinized and subcultured in 24-well, 12-well or
six-well culture plates or 25 cm2 culture flasks, according to the
experimental needs or 75 cm2 culture flasks (Corning) for main-
taining the cells in culture.
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Effects of a TPP-1 deficiency on mitochondria
As control, matching the nuclear background of LINCL cells,
24 h after seeding, LINCL were washed with PBS and incubated
or not for 48 h with 10 nM purified recombinant TPP-1 protein
(kindly provided by P. Lobel, Piscataway, NJ, U.S.A.) diluted
in complete MEM. At the end of the incubation, media were
removed and replaced by fresh complete MEM. All experiments
were carried out 72 h later when the enzymatic activity was fully
recovered (up to 150 % of the enzymatic activity found in CTL
cells).
TPP-1 activity assay
CTL and LINCL fibroblasts were seeded at a density of 500 000
cells in 75 cm2 culture flasks. After 48 h of incubation in the
presence or absence of purified recombinant TPP-1, followed by
3 days of recovery, the TPP-1 activity was assayed in cell lysates
after membrane solubilization in 0.2 % Triton X-100, in 50 mM
acetate buffer; pH 5.0 containing 1 mM TPP-1 substrate (Ala-
Ala-Phe-7-amido-4-methylcoumarin, Sigma) as previously de-
scribed [25]. The reaction was stopped by the addition of 50 mM
glycine buffer, pH 10.5 supplemented with 5 mM EDTA and
0.5 % Triton X-100. Finally, the fluorescence was measured with
a spectrofluorimeter (SLM Instruments, Inc.) (λexc, 350 nm; λem,
420 nm). Autofluorescence values were subtracted from fluor-
escent signals and results were normalized for protein content,
determined by the Pierce 660 nm Protein Assay kit (Thermo Sci-
entific).
Mitochondrial abundance, membrane potential and
flow cytometry analyses
Mitochondrial abundance was assessed in LINCL cells loaded
or not with TPP-1 enzyme. Briefly, cells were seeded in 6-well
culture plates at a density of 100000 cells/well. After 48 h of
incubation in the presence or absence of purified recombinant
TPP-1 (10 nM), followed by 3 days of recovery, cells were stained
with 100 nM MitoTracker Green FM (Molecular Probes) as pre-
viously reported [26]. Cells were analysed by flow cytometry
with a FACScalibur (BD Biosciences), using the FL1-H channel.
Data were processed using the BD CellQuestTM Pro software.
MCFRs (mean channel fluorescence ratios) were calculated for
each condition (LINCL and LINCL + TPP-1) by calculating the
ratio between the Mitotraker Green mean fluorescence intensities
and the mean values of autofluorescence intensities measured for
their corresponding unlabelled cells, used as negative controls.
Mitochondrial membrane potential was assessed in LINCL
cells loaded or not with 10 nM TPP-1 enzyme. Briefly, cells were
seeded in 6-well culture plates at a density of 100000 cells/well.
After 48 h of incubation in the presence or absence of purified
recombinant TPP-1, followed by 3 days of recovery, cells were
incubated for 30 min with 25 nM TMRE (tetramethylrhodamine
ethyl ester, perchlorate; Molecular Probes). Cells were then rinsed
with ice-cold PBS, trypsinized using 0.25 % (w/v) trypsin-EDTA
(Gibco), rinsed once with PBS and resuspended in 500 μl of
Hepes buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, 5 mM KCl,
1 mM MgCl2.6H2O). Cells were analysed by flow cytometry with
a FACScalibur (BD Biosciences), using the FL1-H channel. Data
were processed using the BD CellQuestTM Pro software. MCFRs
were calculated for each condition (LINCL and LINCL + TPP-
1) by calculating the ratio between the TMRE mean fluorescence
intensities and the mean values of autofluorescence intensities
measured for the corresponding unlabelled cells, used as negative
controls.
Western blot analyses
Western blot analyses were performed by IR fluorescence (Odys-
sey Scanner, Li-Cor) [27]. LINCL cells were seeded at a density
of 500000 cells in 75 cm2 culture flasks. After 48 h of incubation
in the presence or absence of purified recombinant TPP-1, fol-
lowed by 3 days of recovery, cells were scraped in 10 ml of com-
plete MEM and centrifuged for 5 min at 93 g. Cell pellets were
washed thrice with ice-cold PBS and lysed in 20 μl of lysis buffer
[7 M urea, 2 M thiourea, pH 8.5, CHAPS 4 % (v/v), 60 mM DTT
(dithiotreitol), 1 mM Na3VO4 (sodium orthovanadate), 10 mM
PNPP (p-nitrophenyl phosphate), 10 mM 2-glycerophosphate,
5 mM sodium fluoride and CompleteTM]. After incubation on ice
for 30 min, cell lysates were centrifuged for 10 min at 15 700 g
(4 ◦C) and the supernatants were collected (clear cell lysates).
Protein concentration was determined using the Pierce 660 nm
Protein Assay kit (Thermo Scientific). Amounts corresponding
to 15 μg of proteins were resolved on 3–8 % or 12 % bis-Tris
gels (NuPage, Invitrogen). At the end of the migration, proteins
were transferred onto PVDF membranes (Millipore). The semi-
dry electrotransfer was performed during 2 h. Unspecific binding
sites were then blocked by incubating the membranes for 1 h at
room temperature (21◦C) with 15 ml of blocking solution (Li-Cor
Odyssey Infrared Imaging System blocking buffer diluted twice
in PBS). Western blot analysis was performed with primary an-
tibodies against HADHA (hydroxyacyl-CoA dehydrogenase/3-
ketoacyl-CoA thiolase/enoyl-CoA hydratase, ab54477, Abcam),
β-subunit ATPsynthase (A21350, Molecular Probes), mt-HSP70
(heat-shock protein 70) (804-077-R100, Alexis Biochemical),
Fis1 (no. HPA017430, Sigma), Drp1 (no. 611112, BD Transduc-
tion Laboratories), Opa1 (no. 612606, BD Transduction Laborat-
ories), Mfn1 (no. WH0055669H4, SIGMA), Mfn2 (no. ab50838,
Abcam), BNIP3 (no. ab10433, Abcam) used at a 1:1000 dilu-
tion, and incubated overnight at 4 ◦C. For the protein detection,
an IRDye-conjugated secondary antibody (Li-Cor) was used at a
1:5000 dilution. Protein loading was verified by the immunode-
tection of either α-tubulin or β-actin. The fluorescence intensity
of the bands corresponding to the protein of interest was quanti-
fied using the Odyssey software (Li-Cor) and normalized by the
fluorescence intensity of the bands corresponding to the α-tubulin
or β-actin.
Gene expression and real-time RT–qPCR (reverse
transcription-quantitative PCR)
LINCL fibroblasts were seeded at a density of 150 000 cells
per 25 cm2 culture flask. After 48 h of incubation in the
presence or absence of purified recombinant TPP-1 (10 nM),
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followed by 3 days of recovery, total RNA was extracted using
the QIAGEN RNeasy mini kit and the QIAcube machine
(QIAGEN) according to the manufacturer’s instructions.
The concentration of RNA isolated with RNeasy kits was
determined by measuring the absorbance at 260 nm in a UV-
spectrophotometer. Total RNA (1μg) was reverse transcribed
in mRNA using the Transcriptor first strand cDNA synthesis
kit (Roche). Forward and reverse primers for BNIP3 and
GAPDH (glyceraldehyde 3-phosphate dehydrogenase) were
designed using the Primer Express 1.5 software (Applied
Biosystems) BNIP3-F, 5′-TTTGCTGGCCATCGGATT-
3′; BNIP3-R, 5′ACCAAGTCAGACTCCAGTTCTTCA-3′;
GAPDH-F, 5′-ACCCACTCCTCCACCTTTGAC-3′; GAPDH-
R, 5′-GTCCACCACCCTGTTGCTGTA-3′. Amplification
reaction assays contained SYBR Green PCR mastermix (Roche)
and primers at the optimal concentrations. Real-time PCR
was performed with the Abi-Prism 7000 Sequence Detection
System (Applied Biosystems) and the data were subjected to
relative quantification using GAPDH as a reference gene for
normalization. The Ct method was used for each sample in
order to calculate the relative fold change. Data calculation and
normalization were performed according to the method of de
Longueville et al. [28].
Silencing of BNIP3 expression using siRNA (small
interfering RNA)
Cell transfection experiments with siRNA were performed using
double-stranded RNA (SMARTpool, Dharmacon). SiGENOME
non-targeting siRNA Ctl Pool 1 (D-001206-13-20) was used as
a control. LINCL cells were transfected with 10 nM siRNA for
BNIP3 (M-004374-04) using the DharmaFECT1 transfection re-
agent (Dharmacon, T-2001) according to the manufacturer’s in-
structions. Silencing was checked 24 h post-transfection by RT
of total extracted RNA, followed by real-time RT–qPCR. For the
Western blot analyses, cells were lysed 24 h post-transfection in
the same lysis buffer as described before.
Analysis of mitochondrial morphology
The morphology of the mitochondrial network was visualized
in cells stained with 100 nM Mitotracker Green probe (Mo-
lecular Probes). CTL and LINCL fibroblasts were seeded at a
density of 500 000 cells in 75 cm2 culture flasks. After 24 h,
LINCL cells were washed with PBS and incubated for 48 h in
the presence or in the absence of purified recombinant TPP-1
protein diluted in complete MEM. At the end of the incub-
ation, media were removed and replaced by fresh complete
MEM without TPP-1. Before 48 h of staining, cells were cul-
tured in Lab-Tek II culture chambers (VWR) at a density of
15000 cells per chamber. Cells were washed with KRH buf-
fer (Krebs-Ringer Hepes buffer) (125 mM NaCl; 5 mM KCl;
1.3 mM CaCl2; 1.2 mM MgSO4; 25 mM Hepes; pH 7.4) and
incubated for 30 min with 100 nM Mitotracker Green diluted
in KRH + 2 % (w/v) BSA. Mitochondrial morphology was ob-
served using confocal microscopy (λexc, 490 nm; λem, 516 nm)
and analyses of mitochondrial population morphology were per-
formed using the ImageJ software [29]. Briefly, after stain-
ing, two-dimensional micrographs of the mitochondrial net-
works were taken using a confocal microscope (Leica). First,
the length of mitochondria or AR (aspect ratio), meaning the
ratio between the bigger (major) and the smaller (minor) side
for each mitochondrial fragment and the degree of reticulation
or FF (form factor) defined as (Pm2)/4p Am) (where Pm is the
length of the mitochondrial perimeter and Am is the area of
the mitochondria), were determined using the ImageJ software.
The images were processed to maximize the signal/background
ratio using the automatic adjustment of brightness/contrast of the
ImageJ software. After smoothing, the images were filtered us-
ing the hat 7 % 7 kernel. Finally, the major, the minor, the area
and the Pm of each fragment were determined using the ‘analyse
particles’ function of ImageJ. Analyses were performed on at
least 40 cells for each condition.
Immunofluorescence staining and confocal
microscopy
LINCL fibroblasts were seeded at a density of 500000 cells in
75 cm2 culture flasks. The next day, LINCL were washed with
PBS and incubated for 48 h with or without 10 nM purified re-
combinant TPP-1 protein diluted in complete MEM. At the end
of the incubation, media were removed and replaced by fresh
complete MEM without TPP-1. 24 h before the staining, cells
were cultured onto glass coverslips (VWR) in 24-well culture
plates (Corning). Cells were fixed for 10 min with 4 % PFA (par-
aformaldehyde), permeabilized for 5 min with PBS/1 % (v/v) Tri-
ton X-100 and then incubated overnight with antibodies against
Drp1 (no. 611112, BD Transduction Laboratories) or against
Fis1 (no. HPA017430, Sigma), diluted 100 times in PBS/1 %
(w/v) BSA. Finally, cells were incubated for 1 h at room tem-
perature with an Alexa-labelled secondary antibody (Molecu-
lar Probes) diluted 500 times in PBS/1 % (w/v) BSA and pro-
cessed for confocal microscopy (Leica). Nuclei were visualized
by ToPro-3 staining and confocal laser scan microscopy ana-
lyses were performed. For co-localization studies, images from
a selected ROI (region of interest) were overlaid revealing the
co-localized pixels. Threshold and background corrections were
set based on Red-Green scattergram, generating a co-localization
image (co-localized pixels in white) and pixels distribution scatter
plot (co-localized yellow pixels along the diagonal). After setting
background and threshold, the percentage of co-localization was
calculated by Leica LAS-AF image analysis [percentage (%) of
co-localization rate = co-localization area/area foreground; area
foreground = area image − area background] [30].
Mitochondrial O2•− measurement
LINCL fibroblasts were seeded at a density of 20 000 cells in 12-
well plates. After 48 h of incubation in the presence or absence
of purified recombinant TPP-1, followed by 3 days of recovery,
the mitochondrial O2•− abundance was measured using 10 μM
MitoSOXTM Red specific dye (Molecular Probes) according to
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the manufacturer’s instructions. When indicated, 10 μM antimy-
cin A was added for 15 min after cell loading with MitoSOXTM.
Fluorescence intensities were measured using a spectrofluori-
meter (λexc, 485 nm; λem, 520 nm) and, after subtraction of the
autofluorescence value from experimental values, fluorescence
intensities were normalized for protein content.
Measurement of the mitochondrial matrix calcium
LINCL fibroblasts were seeded at a density of 10 000 cells in
24-well plates. After 48 h of incubation in the presence or ab-
sence of purified recombinant TPP-1, followed by 3 days of
recovery, the [Ca2 + ]mt (mitochondrial matrix Ca2 + ) was as-
sessed using 2 μM X-Rhod-5F fluorescent probe according to
the manufacturer’s instructions. When indicated, 10 μM iono-
mycin, a calcium-specific ionophore known to increase the cyto-
plasmic calcium concentration [31], was added for 10, 20 or
30 min to cells loaded with X-Rhod-5F. Fluorescence intensities
were measured using a spectrofluorimeter and fluorescence val-
ues were normalized for DNA content after subtraction of auto-
fluorescence from experimental values, as previously described
[32].
Statistical analysis
Data from at least three independent experiments are presented as
means +− S.D. or +− S.E.M. and were analysed with the appropri-
ate statistical test such as the Student’s t test, the Mann–Whitney
Rank Sum test, ANOVA-1 followed by a Dunnett’s test or AN-
OVA 2 followed by a Holm–Sidak test, as advised by the software
SigmaStat 3.1. Differences between means were only considered
as statistically significant when P value was <0.05.
RESULTS
TPP-1 activity in LINCL cells
Numerous studies performed on skin fibroblasts or on other cell
lines derived from patients affected by LSDs suffer from the use,
as controls, of cells from healthy relatives or unrelatives. The dif-
ficulty of finding good controls might hamper the interpretation
of experimental data as numerous differences (in terms of protein
abundance, modifications of gene expression or changes in the
activity of transcription factors, etc.) that exist between different
cell lines might result from their different genetic background
rather than from the effect of the lysosomal hydrolase deficiency
itself. To circumvent this problem, we decided to restore the
TPP-1 activity in LINCL cells, using a recombinant pro-enzyme
produced by CHO (Chinese-hamster ovary) cells, as previously
described [25]. As expected, when LINCL cells were incubated
with 10 nM TPP-1 proenzyme for 48 h and maintained for an ex-
tra 3 days in culture, the TPP-1 activity in LINCL cells could be
efficiently restored (Figure 1). Actually, the TPP-1 activity was
even slightly but significantly higher than the enzymatic activity
Figure 1 TPP-1 activity in control fibroblasts, LINCL cells and
LINCL loaded with recombinant TPP-1
TPP-1 activity was measured in CTL and LINCL cells pre-incubated in the
presence (LINCL+ TPP-1) or in the absence (LINCL) of 10 nM recom-
binant TPP-1 for 48 h using the synthetic substrate Ala–Ala–Phe–AMC
(AAF–AMC). Briefly, at the end of the incubation with the recombinant
enzyme, cells were maintained for 72 h in culture with fresh medium
without TPP-1. Cells were then homogenized in ice-cold isotonic sucrose
and membranes were solubilized with Triton X-100. TPP-1 activity was
assayed in 50 mM acetate buffer (pH 5.0) containing 5 mM 4-methyl-
umbelliferyl derivative as substrate. The fluorescence of 4-methylumbel-
liferone released was measured in a spectrofluorimeter (λexc, 350 nm;
λem, 460 nm). Results were calculated as arbitrary fluorescence units
normalized for protein content (AFU/μg of proteins) and expressed in
percentages of CTL cells as means+−S.D. (n=3). **, ***: significantly
different from CTL cells with P<0.01 and P<0.001 respectively. ###:
significantly different from LINCL cells loaded with TPP-1 with P<0.001
as determined by an ANOVA-1 followed by a Dunnett’s test.
measured in healthy, but unrelated, control fibroblasts (Figure 1).
While the restoration of TPP-1 activity was already observed after
the 48-h incubation with the enzyme (results not shown), the extra
time in culture allowed us to assess the stability of the recovery
and the putative reversibility of changes induced by the enzyme
deficiency.
TPP-1 deficiency has no impact on the
mitochondrial population abundance
Recent data in the literature have suggested that the mitochon-
drial abundance was reduced in two NCL forms (CLN6 and
CLN1) when compared with healthy unrelated skin fibroblasts
[13]. Thus, we wanted to determine the putative effect of a
TPP-1 deficiency on the mitochondrial abundance. We first as-
sessed the mitochondrial mass by flow cytometry, in LINCL
and LINCL cells pre-incubated with TPP-1 and then stained
with MitoTracker Green, a fluorescent dye known to accumu-
late in mitochondria irrespective of the mitochondrial mem-
brane potential [33]. Figure 2(A) shows that the mitochondrial
abundance in LINCL cells is not modified upon recovery of
the TPP-1 activity. Even though the use of this fluorescent
probe did not allow us to detect any quantitative modification
of the mitochondrial population, it is possible that modifications
in the abundance of some proteins could nevertheless occur in
LINCL cells. To test this hypothesis, we analysed the abundance
of several mitochondrial proteins that fulfil different functions,
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such as oxidative phosphorylation (β-subunit of ATPsynthase),
fatty acid β-oxidation (HADHA) or mitochondrial protein fold-
ing in the matrix (mt-HSP70), in LINCL and LINCL cells loaded
with TPP-1. Our results show that the recovery of the TPP-1
activity has no effect either on the abundance of the β-subunit
of ATPsynthase or on the abundance of HADHA (Figures 2B
and 2C). However, it significantly increases the abundance of
mt-HSP70, demonstrating that the abundance of some mitochon-
drial proteins might be reversibly changed within mitochondria of
TPP-1-deficient cells (Figures 2B and 2C). We therefore decided
to analyse the expression of 168 nuclear genes encoding mito-
chondrial proteins, using both the mitochondrial PCR array and
the mitochondrial energy metabolism PCR array from SABios-
ciences (Qiagen) (results not shown). Among the modifications
observed in TPP-1- rescued LINCL cells, only the decrease in the
expression of the gene encoding the protein BNIP3 could be val-
idated by real-time RT–qPCR (Figure 3A). Taken together, these
results suggest that there are no major changes in the mitochon-
drial abundance and most likely no change in the biogenesis of
mitochondria in cells that display a deficiency in TPP-1 activity.
TPP-1 deficiency induces an increase in the
expression of BNIP3
As the transcriptional expression of BNIP3 seemed to be down-
regulated in TPP-1-rescued LINCL cells, we analysed the abund-
ance of this protein by Western blot analysis. In accordance with
the RT–qPCR results, Figures 3(B) and 3(C) show that the abund-
ance of BNIP3 is significantly reduced in LINCL cells loaded
with TPP-1 when compared with LINCL cells. BNIP3 is a mem-
ber of the Bcl2 family [34], which has now also been considered
as a regulator of mitochondrial morphology and function [35–37].
Indeed, the overexpression of BNIP3 can trigger mitochondrial
fission by increasing the recruitment of Drp1 onto the mitochon-
dria, but also by inhibiting Opa1 activity [36,38]. Knowing that
the mitochondrial network is more fragmented in several mod-
els of lysosomal storage disorders [12,18], we next analysed the
putative impact of a TPP-1 deficiency on the mitochondrial mor-
phology in LINCL cells.
Mitochondrial network morphology was assessed in cells
stained with 100 nM Mitotracker Green and visualized by fluor-
escence confocal microscopy. The mitochondrial network is
reticulated and interconnected in healthy control cells (Fig-
ure 4A), a phenotype found in the majority of cell types [15]. A
pre-incubation of these cells for 30 min with 20 μM FCCP
(carbonyl cyanide p-trifluoromethoxyphenylhydrazone), a pro-
tonophore that uncouples mitochondrial respiration from ATP
production, induces a fragmentation of the mitochondrial net-
work as previously reported [18]. These observations can be
quantified on recorded micrographs using the ImageJ software.
As expected, both parameters, the AR and the FF which give an
indication about the length of mitochondrial segments and their
degree of reticulation, respectively, are significantly reduced upon
FCCP treatment (Figures 4B and 4C). More interestingly, the
mitochondrial network also appears more fragmented in LINCL
cells, when compared with LINCL cells that recovered a TPP-
Figure 2 Effects of a TPP-1 deficiency on the mitochondrial
abundance
(A) Mitochondrial population abundance was analysed in LINCL cells
pre-incubated with (LINCL+ TPP-1) or without (LINCL) recombinant
TPP-1. Cells were then stained with 100 nM MitoTracker Green for
30 min and fluorescence was detected by flow cytometry as described
in the Material and methods section. Results are expressed as Mito-
Tracker Green Fluorescence MCFR calculated from autofluorescence
signals measured for corresponding unstained cells and represent
means+−S.D. (n=3). NS, non-significantly different from LINCL cells
as determined by a Student’s t test. (B) The abundance of HADHA,
β -subunit of ATPsynthase and mt-HSP70 was determined by Western
blot analysis performed on 15 μg of clear cell lysates prepared from
LINCL cells pre-incubated (LINCL+ TPP-1) or not (LINCL) with recombin-
ant TPP-1. Equal protein loading was controlled by the immunodetec-
tion of β -actin or α-tubulin (n=3). (C) Quantification of the abundance
of β -subunit of ATP synthase (grey columns) HADHA (white columns),
and mt-HSP70 (black columns) on blots presented in (B). Results are
calculated as fluorescence intensity normalized for α-tubulin or β -actin
and expressed in percentages of LINCL cells as means+−S.D. (n=3).
*: significantly different from LINCL cells with P<0.05 as determined
by a Student’s t test.
1 activity for 5 days (Figures 4A–4C). In order to determine
whether or not BNIP3 is involved in the onset of the fragmented
mitochondrial network observed in TPP-1-deficient cells, we ana-
lysed the morphology of the mitochondrial network in LINCL
cells and LINCL cells loaded with TPP-1 after silencing the
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Figure 3 Effects of a TPP-1 deficiency on the expression of BNIP3
(A) Total RNA was extracted from LINCL cells pre-incubated with
(LINCL+ TPP-1) or without (LINCL) TPP-1, reverse transcribed and amp-
lified by real-time RT–qPCR in the presence of BNIP3 primers and SYBR
green. GAPDH was used as reference gene for data normalization. Res-
ults are expressed in percentages of the mRNA abundance determined
in LINCL cells and represent means+−S.D. (n=3). *: significantly dif-
ferent from LINCL cells with P<0.05 as determined by a Student’s
t test. (B) The protein abundance of BNIP3 was determined by West-
ern blot analysis performed on 15 μg of clear cell lysates prepared
from LINCL cells pre-incubated (LINCL+ TPP-1) or not (LINCL) with TPP-1
(n=3). Equal protein loading was controlled by the immunodetection of
α-tubulin. (C) Quantification of the Western blot presented in (B). Fluor-
escence intensity of the band of interest was normalized for α-tubulin
and expressed as percentages of LINCL cells. Results are means+−S.D.
(n=3). *: significantly different from LINCL cells with P<0.05 as de-
termined by a Student’s t test.
expression of BNIP3 using a RNAi approach. Western blot ana-
lysis revealed a strong decrease in the abundance of BNIP3 pro-
tein in LINCL cells 24 h post-transfection with a pool of four spe-
cific RNAs (siBNIP3) when compared with a control pool RNA
(siCTL) (Figure 5A). However, the inhibition of BNIP3 expres-
sion does not reverse the mitochondrial fragmentation observed
in LINCL cells (Figure 5B). Indeed, in LINCL cells transfected
with siCTL, the AR is significantly higher (Figure 5C) whereas
the FF tends to be higher (Figure 5D) after recovery of the TPP-1
activity, supporting the idea of a mitochondrial fragmentation in
LINCL cells. However, neither the AR nor the FF are increased
upon silencing of BNIP3 expression both in LINCL cells and
in LINCL cells loaded with TPP-1 (Figures 5C and 5D). These
results indicate that BNIP3 silencing does not reverse the mito-
chondrial fragmentation in LINCL cells and does not prevent the
recovery of the mitochondrial network after TPP-1 loading.
TPP-1 deficiency induces a decrease in the
abundance of Mfn1 and Mfn2 proteins
To get information about putative mechanisms leading to mito-
chondria fragmentation in LINCL cells, we next quantified the
abundance of both Mfn1 and Mfn2 (regulating fusion events
of OMM), Opa1 (regulating fusion events of the IMM), Fis1
and Drp1 (controlling fission events), the major proteins regu-
lating the morphology of the mitochondrial reticulum [16]. The
Western blot analysis revealed that the abundance of the pro-
teins Fis1, Drp1, and Opa1 is comparable in LINCL and LINCL
cells loaded with TPP-1 (Figure 6). In contrast, the recovery
of the TPP-1 activity in LINCL cells significantly increases the
total abundance of Mfn1 and Mfn2 (Figure 6). As mentioned
before, Drp1 is a cytosolic GTPase that is recruited onto mito-
chondria upon activation [39]. Given its mechanism of action,
we wondered whether Drp1 could be differentially targeted to
mitochondria of LINCL cells, even if the total abundance of this
protein is unchanged in these cells. To test this hypothesis, we
analysed the putative co-localization between Drp1 and the mito-
chondrial protein Fis1 (Figure 7A), a protein known to participate
in the mitochondrial recruitment of this GTPase [16]. However,
the percentage of co-localization between these two proteins is
not modified in LINCL cells when compared with LINCL cells
loaded with TPP-1 (Figure 7B) suggesting that Drp1 is not dif-
ferentially recruited onto the mitochondria of LINCL cells. It is
thus unlikely that these proteins regulating fission events might
contribute to the observed fragmentation of the mitochondrial
network in LINCL cells. Altogether, our findings suggest that
the more fragmented mitochondrial network observed in LINCL
cells would more likely result from a deficit of mitochondrial
fusion than from an enhanced fission of mitochondria.
Mitochondrial membrane potential, abundance of
O2•− and mitochondrial matrix calcium
concentration
The fragmentation of mitochondria is often, but not always [40],
associated with a decrease in the mitochondrial membrane po-
tential. It is also known that mitofusins (Mfn1 and Mfn2) can
be targeted for degradation in response to IMM depolarization
[41]. Therefore we analysed the mitochondrial membrane po-
tential in cells loaded with 25 nM TMRE (low concentration
in non-quenching conditions) using flow cytometry. As shown in
Figure 8(A), the mitochondrial membrane potential is signific-
antly increased in LINCL cells that recovered a TPP-1 activity.
This result suggests that the mitochondrial membrane potential
is lower in LINCL cells, a finding in agreement with a more
fragmented mitochondria phenotype in these cells. It should also
be emphasized that the change in the TMRE fluorescent signal
for TPP-1-loaded cells is unlikely to result from a difference in
mitochondrial mass between LINCL and LINCL cells loaded
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c© 2013 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/
by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
249
G. Van Beersel and others
Figure 4 Effects of a TPP-1 deficiency on mitochondrial morphology
(A) Representative confocal micrographs of mitochondrial morphology of fibroblasts pre-incubated with (CTL+ FCCP) or
without (CTL) 20 μM FCCP for 30 min and of LINCL cells pre-incubated with (LINCL+ TPP-1) or without (LINCL) TPP-1 and
stained with 100 nM Mitotracker Green. (B and C) The length (or AR) and the degree of branching of mitochondria (or FF)
were determined on micrographs using the ImageJ software as described in the Material and methods section. Results
are expressed in either AR (B) or FF ratio (C) and represent means+−S.E.M. (n 59 from four independent experiments).
###: significantly different from CTL cells with P<0.001; *, ***: statistically different from LINCL cells as determined by
a Mann–Whitney Rank Sum test with P<0.05 and P<0.001, respectively.
with TPP-1 as we failed to detect any significant difference in
the abundance of the organelle between these cells with the Mi-
totracker Green staining (Figure 2A).
Interestingly, in models of MLIV or nephropathic cystinosis,
mitochondrial fragmentation and aberrations have also been as-
sociated with a decrease in the mitochondrial calcium buffering
capacity and/or with an increased production of ROS [18,19].
To assess the putative effect of the morphological changes on
these parameters, we first quantified the mitochondrial abund-
ance of superoxide anion radicals O2•− in LINCL and LINCL
cells loaded with TPP-1 cells using the MitoSOXTM fluorescent
dye [42]. We found that the O2•− abundance, though slightly
lower in LINCL cells that recovered TPP-1 activity, was not sig-
nificantly different from fluorescent signals measured in LINCL
cells (Figure 8B). As a positive control, we also incubated cells
for 15 min with 10 μM antimycin A, an inhibitor of the com-
plex III of the respiratory chain, known to induce ROS produc-
tion at this concentration [43]. In these conditions, as expected,
the O2•− production is increased (Figure 8B). However, the in-
crease is comparable for both LINCL cells and LINCL cells that
recovered TPP-1 activity. These results suggest that, in terms
of ROS production, both LINCL and LINCL cells loaded with
TPP-1 for 5 days respond similarly to an inducer of mitochondrial
oxidative stress.
Then, using X-Rhod-5F, a specific fluorescent probe allowing
the measurement of mitochondrial matrix calcium concentration
[44], we determined the putative effects of a TPP-1 deficiency
on the [Ca2 + ]mt concentration homoeostasis (Figure 8C). We ob-
served that the basal [Ca2 + ]mt was not modified by the TPP-1 de-
ficiency. In order to assess the buffering capacity of mitochondria,
LINCL and LINCL fibroblasts that recovered TPP-1 activity were
loaded with X-Rhod-5F and incubated for 10, 20 and 30 min with
10 μM ionomycin, a calcium-specific ionophore known to in-
duce changes in the cytosolic calcium concentration [31]. After a
challenge with ionomycin, a strong and significant increase in the
[Ca2 + ]mt was observed. However, this increase was comparable
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Figure 5 Effects of BNIP3 silencing on the mitochondrial morphology of LINCL and LINCL cells that recovered TPP-1
activity
(A) Efficiency of siRNA-mediated knock down of BNIP3 in LINCL cells. The abundance of BNIP3 was determined by Western
blotting analysis performed on 15 μg of clear cell lysates prepared from untransfected LINCL cells and cells transfected
either with a pool of four specific siRNAs targeting BNIP3 (siBNIP3) or with a control pool of siRNAs (siCTL). Equal protein
loading was controlled by the immunodetection of α-tubulin. (B) Representative confocal micrographs of mitochondrial
morphology of LINCL and LINCL cells with restored TPP-1 activity, transfected either with a control pool of siRNAs (siCTL) or
with a pool of four specific siRNAs targeting BNIP3 (siBNIP3) and then stained with 100 nM Mitotracker Green. The length
(AR) and the degree of branching of mitochondria (FF) were determined on micrographs using the ImageJ software, as
described in the Material and methods section. Results are expressed in either AR (C) or FF ratio (D) as means+−S.E.M.
(n50 from three independent experiments). *: significantly different from LINCL cells transfected with the siCTL with
P<0.05, as determined by an ANOVA-2 followed by a Holm–Sidak test and by a Mann–Whitney Rank Sum test for the AR
and the FF, respectively. NS, not significantly different from LINCL cells transfected with the siCTL.
in both LINCL and LINCL cells loaded with TPP-1, suggest-
ing that the calcium buffering capacity is not altered in TPP-1-
deficient fibroblasts (Figure 8C).
BNIP3 sensitizes LINCL cells to antimycin
A-induced mitochondrial fragmentation
The final question we addressed in this study was about the role
of BNIP3 overexpression in LINCL cells. Several studies have
shown that, when ectopically overexpressed, BNIP3 is detected
in the mitochondria as a single monomer loosely attached to the
OMM [45]. Although the molecular mechanisms involved in
the activation of BNIP3 are not completely elucidated, it has been
reported that it requires an increase in cytosolic pH, in cytosolic
calcium concentration or generation of an oxidative stress [46].
These modifications would trigger BNIP3 embedding into the
OMM, its dimerization and, in fine, mitochondrial dysfunction.
It is therefore possible that even if this protein is overexpressed
in LINCL fibroblasts, it might be kept in an inactive state re-
quiring appropriate stimuli to become biologically active. This
hypothesis could explain why this protein does not seem to par-
ticipate in the fragmentation of mitochondria in LINCL cells.
In order to test this hypothesis, we analysed the mitochondrial
morphology in cells exposed to high concentrations of antimy-
cin A. LINCL and LINCL cells loaded with TPP-1 cells were
first incubated with different concentrations of antimycin A to
determine the most appropriate concentration to induce changes
in mitochondrial morphology. We noticed that a 1 h incubation
with 25 μM antimycin A caused a mitochondrial fragmentation
significantly higher in LINCL cells when compared with LINCL
cells loaded with TPP-1 (results not shown). Then, we repeated
the same experiment on fibroblasts in which BNIP3 expression
was silenced with siRNA (Figure 9A). The observations of the
mitochondrial morphology in cells pre-incubated with antimycin
A for 1 h clearly revealed a more important fragmentation of the
mitochondrial network in LINCL cells incubated with a control
siRNA when compared with pre-incubated LINCL cells in which
the expression of BNIP3 was silenced, as demonstrated by the
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Figure 6 Effects of a TPP-1 deficiency on the abundance of major
regulators of mitochondrial dynamics
(A) The abundance of Opa1, Drp1, Mfn2, Mfn1 and Fis1 was determ-
ined by fluorescence Western blot analysis on 15 μg of clear cell lysates
prepared from LINCL cells pre-incubated with (LINCL+ TPP-1) or without
(LINCL) TPP-1 (n=3). Equal protein loading was controlled by the im-
munodetection of α-tubulin. Asterisks denote non-specific and unchar-
acterized bands. (B) Quantification of the abundance of Opa1 (white
columns), Drp1 (grey columns), Mfn2 (hatched lines), Mfn1 (dots) and
Fis1 (black columns) on the blots shown in (A). Results are calculated
as fluorescence intensity normalized for α-tubulin and expressed as a
percentage of LINCL cells as means+−S.D. (n=3). *: significantly dif-
ferent from LINCL cells with P<0.05, as determined by a Student’s
t test.
significant increase in both the AR and the FF parameters (Fig-
ures 9A and B). In contrast, in LINCL cells that recovered TPP-1
for 5 days, BNIP3 silencing has no impact on either the AR or the
FF after addition of antimycin A. This could be linked to
the lower expression of BNIP3 in these cells (Figure 3). These
results suggest that although BNIP3 does not seem to be involved
in the fragmentation of the mitochondrial network in LINCL cells
in basal conditions, it could contribute to enhancing this process
during mitochondrial oxidative stress conditions.
DISCUSSION
Several studies show that the mitochondrial population exhib-
its morphological and functional alterations in response to a
lysosomal dysfunction and, therefore, suggest that mitochondrial
impairment could be a common characteristic in the pathogenesis
of LSDs [12,13,17–19]. These monogenic diseases, notably the
NCLs, are often associated with neurodegeneration [7]. Interest-
ingly, modifications of the mitochondrial morphology leading to
alterations of mitochondrial functions, such as ATP production,
have been associated with the pathogenesis of several neurode-
generative disorders caused by the intracellular accumulation of
proteins [47]. For example, in AD (Alzheimer’s disease), the
NO (nitric oxide) produced in response to β-amyloid protein
accumulation was shown to trigger mitochondrial fission, syn-
aptic loss and neuronal damage through the activation of Drp1 by
S-nitrosylation [48]. Likewise, in Huntington’s disease, the accu-
mulating mutant Huntingtin protein also increased the activity of
this GTPase, leading to an excessive mitochondrial fragmentation
and, in fine, to synaptic degeneration [49]. Moreover, pharmaco-
logical molecules that stimulate mitochondrial biogenesis were
also reported to have beneficial effects on the neuronal survival
and atrophy, suggesting an essential role of mitochondrial dys-
function in the pathogenesis of these diseases [50,51]. So far,
while modifications in the dynamics of mitochondria have been
reported in several LSDs, the molecular mechanisms that have
been proposed were mainly related to a defect in the selective
degradation of damaged mitochondria by the autophagic process
(also called mitophagy) [18,52,53]. To our knowledge, the ex-
pression of regulators of mitochondrial fusion and fission events
has never been studied in the context of these pathologies.
The aim of this study was to analyse the putative impact of a
TPP-1 deficiency on the mitochondrial population in fibroblasts.
To allow a more reliable interpretation of the results, the con-
trol fibroblastic cells were constituted of TPP-1-deficient cells in
which TPP-1 activity was restored using a protocol previously
described [25]. This kind of control is essential to avoid drawing
conclusions from differences that could be merely due to differ-
ences in the genetic backgrounds between fibroblast cell lines
used for controls and lysosomal deficiency. However, one cannot
completely exclude that some modifications produced by the en-
zymatic deficiency persist even after enzyme recovery because
some alterations might require higher dose and/or longer incub-
ation time to be reversed or could be irreversible. In addition,
the substrates of the deficient enzyme that accumulate upon en-
zymatic deficiency might undergo a chemical modification such
as oxidation, preventing their degradation when the enzymatic
activity is recovered [54].
We first analysed the effect of a TPP-1 deficiency on the
abundance and the morphology of the mitochondrial population.
Our results show that even though the abundance of mitochon-
dria, determined by the Mitotracker Green staining followed by
FACS analysis, is not modified in LINCL fibroblasts, these cells
clearly exhibit a reversible fragmentation of the mitochondrial
network. These findings support the conclusions of Kiselyov and
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Figure 7 Cellular distribution of Drp1/Fis1 and colocalization of these proteins as visualized by immunofluorescence
confocal microscopy
(A) Representative micrographs of Drp1 and/or Fis1 immunostaining taken with a confocal microscope. LINCL cells were
cultured on coverslips and were incubated with (LINCL+ TPP-1) or without (LINCL) TPP-1 before being fixed, permeabilized
and incubated with antibodies raised against Fis1-(red) or Drp1-(green). In merged micrographs, the appearance of the
yellow fluorescence signals reflects the colocalization between both proteins. Nuclei were stained with TO-PRO-3 iodide
(blue fluorescence). (B) The co-localization between Drp1 and Fis1 was quantified using the co-localization module of
Leica LAS AF software. The results are expressed as the percentages of co-localization (means+−S.D.; n=20). NS,
non-significantly different from LINCL cells, as determined by a Student’s t test.
co-workers [18]. The mitochondrial fragmentation seems to be a
common feature in the LSDs since it has been described in many
cell types that display various and unrelated LSDs [12,13,17–
19]. As mentioned above, a first hypothesis to explain changes
in morphology in cells affected by LSDs is that the impairment
of the autophagic process induces the accumulation of unde-
graded and ‘old’ fragmented mitochondria. This hypothesis re-
lies on the observation that the mitochondrial fragmentation in
MLIV fibroblasts (deficient for the mucolipin 1) can be repro-
duced in healthy cells incubated with 3-MA (3-methyl adenine),
an inhibitor of the class III phosphatidylinositol 3-kinase activity
known to inhibit autophagy [18]. However, it has also been sug-
gested that stimulation, rather than inhibition, of the autophagic
process could lead to the fragmentation of the mitochondrial
network observed in MLII and MLIII skin fibroblasts. Indeed,
Sakai and co-workers showed that both the mitochondrial mor-
phology and the mitochondrial membrane potential were restored
following the inhibition of autophagosome formation with 3-MA
[53]. However, our preliminary results do not support any induc-
tion or impairment of this process either in the TPP-1-deficient
cells or in the brain from 120-days-old CLN2 − / − mice, since
we failed to observe any conversion of LC3-I into LC3-II, a
frequently used marker of macroautophagy (results not shown).
Furthermore, a deficient autophagic mechanism is expected to
provoke a global accumulation of mitochondria. In our experi-
mental conditions, a global accumulation of mitochondria was not
observed in LINCL cells as determined by the abundance analysis
of mitochondrial population stained with the Mitotracker Green
fluorescent probe (Figure 2). Another hypothesis proposed by
Simonati and co-workers to explain the fragmentation of mito-
chondria in LSDs, is that lysosomal biogenesis and proliferation
observed in response to the accumulation of undegraded substrate
could induce a mechanical stress on the mitochondrial membrane,
causing a decrease in the mitochondrial membrane potential and,
in fine, mitochondrial fragmentation [13].
The major findings of our study lie in the mechanisms by
which the mitochondrial fragmentation could occur in LINCL
cells. Indeed, we found that this phenomenon is associated with
a decrease in the abundance of Mfn1 and Mfn2, whereas the
abundance of Drp1 and Fis1 (two proteins involved in
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Figure 8 Effects of a TPP-1 deficiency on the mitochondrial membrane potential, mitochondrial matrix calcium concen-
tration and mitochondrial O2•− content
(A) The mitochondrial membrane potential was analysed in LINCL cells pre-incubated with (LINCL+ TPP-1) or without (LINCL)
recombinant TPP-1, using the specific mitochondrial membrane potential probe TMRE. Cells were stained or not (to allow
autofluorescence determination from cells without dye) with 25 nM TMRE for 30 min and fluorescence was analysed by
flow cytometry. Results are expressed as TMRE fluorescence MCFR as means+−S.D. (n=3), ***: significantly different
from LINCL cells with P<0.001 as determined by a Student’s t test. (B) The mitochondrial O2•− content was assessed
in LINCL cells pre-incubated with (LINCL+ TPP-1) or without (LINCL) TPP-1 using the specific mitochondrial MitoSOXTM Red
dye. Cells were stained (white and grey columns) or not (to allow autofluorescence determination from cells without dye)
with 10 μM MitoSOXTM Red specific dye for 10 min and fluorescence intensities were measured using a spectrofluorimeter
(λexc, 485 nm; λem, 520 nm). As a positive control, cells were incubated for 15 min with 10 μM antimycin A (grey columns)
while untreated cells were maintained for 15 min without molecule (white columns). Results were normalized for protein
content and expressed in relative fluorescence arbitrary unit/μg of proteins as means+−S.D. (n=3). ***, ###: significantly
different from untreated LINCL and LINCL+ TPP-1 cells, respectively, with P<0.001 as determined by an ANOVA-2 followed
by a Holm-Sidak’s t test. NS, non-significantly different from LINCL cells. (C) The mitochondrial calcium concentration in
LINCL cells pre-incubated with (LINCL+ TPP1) or without (LINCL) recombinant TPP-1 was determined using X-Rhod-5F,
a specific mitochondrial matrix calcium probe. Cells were stained or not (to allow autofluorescence determination from
cells without dye) with 2 μM X-Rhod-5F fluorescent probe for 30 min and fluorescence intensities were measured in a
spectrofluorimeter (λexc, 580 nm; λem, 612 nm). To test mitochondrial calcium buffering capacity, cells were incubated
with 10 μM ionomycin for 10 min (grey columns), 20 min (dark grey columns) or 30 min (black columns) or left untreated
(white columns). Results are expressed as Relative Fluorescence Units (RFU) normalized for DNA content determined by
propidium iodide (IP) staining as means+−S.D. (n=9). ***, Significantly different from LINCL cells with P<0.001, ###:
significantly different from LINCL+ TPP-1 cells as determined by a Mann–Whitney Rank Sum test. NS, non-significantly
different from LINCL cells.
mitochondria fission) is unchanged, suggesting that mitochon-
drial fragmentation in cells that display a TPP-1 deficiency could
result from a deficit of fusion events. It is noteworthy that a differ-
ential recruitment of Drp1 to Fis1 in LINCL cells is also unlikely
as no modifications in the co-localization of these two proteins
could be observed between LINCL cells and cells that recovered
TPP-1 activity.
Interestingly, in our research of proteins that are differentially
expressed in response to a TPP-1 deficiency, we identified BNIP3,
a BH3-only protein Bcl2 member whose expression has been
described to induce mitochondrial dysfunction characterized by
mitochondrial fragmentation, mitochondrial membrane potential
depolarization and opening of the mitochondrial transition pore
that can, in fine, lead to cell death [23,24]. As a first attempt to
confirm the overexpression of BNIP3 in a more relevant model,
we also analysed the expression of the gene encoding this protein
in the brain of TPP-1-deficient mice. This experiment did not
allow us to show any increase in BNIP3 expression (results
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Figure 9 Effects of BNIP3 silencing on antimycin A-induced mito-
chondrial fragmentation in LINCL cells
(A) Representative confocal micrographs of mitochondrial morphology
in LINCL and LINCL cells that recovered TPP-1 activity. At the end of the
incubations, cells were transfected for 24 h with either a pool of four
specific siRNAs targeting BNIP3 (siBNIP3) or with a control pool of
siRNAs (siCTL), incubated with 25 μM antimycin A for 1 h and eventu-
ally loaded with 100 nM Mitotracker Green before analysis. The length
(AR) and the degree of branching of mitochondria (FF) were determined
using the ImageJ software, as described in the Material and meth-
ods section. Results are expressed in either AR (B) or FF ratio (C) as
means+−S.E.M. (n40 from three independent experiments). **,***:
significantly different from LINCL cells transfected with the siCTL with
P<0.01 or 0.001, respectively, as determined by a Mann–Whitney
Rank Sum test. NS, non-significantly different. NS, non-significantly dif-
ferent from LINCL cells pre-incubated with TPP-1 and transfected with
the siCTL.
not shown). It should be noted that the neurodegeneration ob-
served in the brain of the TPP-1-deficient mice has been described
to affect particular brain regions such as the cerebellum (in which
the Purkinje cells are the most affected cells [9]). Immunochem-
istry studies of the BNIP3 expression in specific areas of the brain
of CLN2 − / − mice over the time course of the disease develop-
ment would be necessary to determine whether this protein could
be involved in the neurodegeneration observed during the LINCL
disease or if the differential expression is restricted to fibroblasts.
Knowing the multiple role of BNIP3 in the regulation of mito-
chondrial morphology, we tested the putative involvement of this
protein in the mitochondrial fragmentation observed in LINCL
cells. Using an RNAi approach, we show that BNIP3 is not
involved in the mitochondrial fragmentation found in TPP-1-
deficient cells (Figure 4), indirectly lending support to a role for
Mfn1 and Mfn2 proteins in the change of mitochondrial mor-
phology in response to TPP-1 deficiency. The relative abund-
ance of the mRNA encoding these proteins is not modified in
LINCL cells (results not shown). Therefore we can hypothesize
that the reduced abundance of both Mfn1 and Mfn2 in LINCL
cells could result from post-translational modifications reducing
their half-life time. Interestingly, it has been recently shown that
mitochondrial depolarization induced by the CCCP (carbonyl
cyanide m-chlorophenylhydrazone; a protonophore) leads to the
recruitment of the E3 ubiquitin ligase PARKIN onto the mito-
chondria. The ubiquitinylated mitofusin proteins would next be
targeted to proteosomal degradation [41], a process that could ex-
plain why we observe a difference in the abundance of mitofusin
proteins in LINCL cells without any change in the abundance of
their transcripts. Even though Drp1 is most probably not involved
in the mitochondrial fragmentation observed in LINCL cells, one
cannot completely rule out the possibility that the activity of
this protein can be specifically modified at the OMM. Indeed,
McBride and co-workers recently showed that SNEP5-mediated
Drp1 deSUMOylation on the mitochondrial membrane enhances
its anchoring into functional oligomers. This leads to an increase
in overall recycling rates of this protein, facilitating mitochondria
fission without any modification of the mitochondrial abundance
of Drp1 [55].
Mitochondrial fragmentation observed in LINCL cells is asso-
ciated with a decrease in the mitochondrial membrane potential
(Figure 8A). Nevertheless, neither the basal mitochondrial matrix
calcium concentration nor the calcium buffering capacity (Fig-
ure 8B) and the mitochondrial ROS abundance (Figure 8C) seem
to be changed in cells affected by the enzymatic defect. Our
results could therefore suggest that contrary to the hypothesis
initially proposed by Kiselyov and co-workers [18], a defect in
calcium handling by the mitochondria is not a general feature of
LSDs. However, in that study, the authors impaired calcium ho-
moeostasis using bradykinin, which induces Ca2 + release from
the ER [56] whereas, in our study, we used ionomycin, a Ca2 + -
specific ionophore that has been isolated from the bacterium
Streptomyces conglobatus [57]. Perhaps, this could explain why
in our model, the mitochondrial fragmentation in LINCL cells
is not associated with a decrease in the mitochondrial calcium
buffering capacity. Indeed, it is well known that mitochondrial
Ca2 + uptake from the ER requires close and physical interac-
tions between both organelles through contact sites or MAMs
(mitochondrial associated membranes) [58]. The lack of Ca2 +
uptake by mitochondria in response to bradykinin or other cal-
cium agonists, such as histamine, suggests that the interactions
between the mitochondria and the ER could be altered in cells
with LSDs [59]. Recently, d’Azzo and co-workers [20] showed,
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in a β-galactosidase-deficient mouse model, that the accumula-
tion of GM1-ganglioside inside the MAMs induces the clustering
of the IP3 receptor-1 (inositol trisphosphate receptor-1), VDAC
(voltage-dependent anion channel) and Grp75, thereby leading
to the formation of Ca2 + mega pores between the two organ-
elles. The authors showed that the treatment of β-galactosidase-
deficient cells with histamine results in a Ca2 + overload in mi-
tochondria, leading in fine to apoptosis [20]. Interestingly, Mfn2
is another protein essential for the tethering between the ER
and the mitochondria and for the efficiency of mitochondrial
Ca2 + buffering in response to stimuli that generate inositol-
1,4,5-trisphosphate [60]. The reduced abundance of that protein
in LINCL cells therefore suggests that the interactions between
both organelles might be less frequent in LINCL cells.
The last question we wanted to address in this study was
to determine the biological role of the overexpressed BNIP3 in
LINCL cells. Knowing that BNIP3 can be expressed at a high
level without being functionally active [34], we decided to ar-
tificially increase mitochondrial ROS production using antimy-
cin A to trigger its activation. Our results clearly indicate that,
although BNIP3 does not seem to be involved in the mitochon-
drial fragmentation observed in a basal state in LINCL cells, it
sensitizes LINCL cells to antimycin A-induced mitochondrial
fragmentation, probably because it is activated in the presence
of ROS. Supporting this interpretation, activation of BNIP3 in
response to an oxidative stress has been described in other exper-
imental models, such as cardiac myocytes exposed to ischaemia
and reperfusion or C6 glioma cells treated with H2O2 [23,61].
In C6 glioma cells exposed to H2O2, it has been shown that
BNIP3 is over-expressed and forms oligomers that in turn, medi-
ate the suppression of the mTOR (mammalian target of rapamy-
cin) pathway and the activation of autophagy, leading to cell
death [61]. Knowing that the involvement of apoptosis in
cell death in NCL diseases is still a matter of debate, the idea
that BNIP3 could mediate and enhance mitochondrial dysfunc-
tion in cells from patients suffering from LINCL in response to
external (oxidative) stress conditions is interesting and their po-
tential role in the neurodegeneration observed in NCLs should
be tested in the future. Interestingly, a recent study has revealed
that TPP-1-deficient cells exhibit a defect in TNFα (tumour nec-
rosis factor α)-induced Bid cleavage, cytochrome c release and
caspase 9 and caspase 3 activation [6]. These authors also men-
tioned that this resistance is no longer observed when cells are
treated with ceramide or staurosporine, two apoptosis inducers
acting through mitochondrial dysfunction, suggesting that this
pathway could be involved in the induced neurodegeneration of
cells affected by a TPP-1 deficiency [6]. The fact that BNIP3-
mediated cell death was shown to be independent of caspase 3
and cytochrome c release in some cell types [24,62], argues in
favour of a putative role of BNIP3 in the cell death observed in
LINCL cells exposed to an external stress. As proposed by Zhao
and co-workers, the BNIP3-mediated cell death would mainly in-
volve the nuclear translocation of endonuclease G, an apoptotic
DNase when released from mitochondria [63].
Eventually, several questions remain to be addressed at the
end of this study such as the identification of the transcription
factor(s) and cell signalling leading to BNIP3 overexpression in
LINCL cells. So far, the expression of the gene-encoding BNIP3
is known to be regulated by the activity of several transcription
factors. Among them, HIF-1 (hypoxia-inducible factor-1) [64],
FOXO3 (forkhead box O3) [65], E2F1 [66] and more recently,
ATF3 (activating transcription factor 3) [67], have been described
as transcriptional activators, unlike p53 [68] and NF-κB (nuc-
lear factor κB) [69] that would act as repressors. The molecular
mechanisms leading to the increased expression of BNIP3 and
the study of the role of this protein in the sensitivity of LINCL
cells to induced apoptosis should be determined in the future to
get a more precise view of the role of this protein in LSDs.
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